AlphaRx, Inc. (ALRX) - Financial and Strategic SWOT Analysis Review

GlobalData, January 2013, Pages: 34

Summary

AlphaRX, Inc. (AlphaRx), formerly known as Logic Tech International Inc., is a specialty pharmaceutical company. It undertakes focuses on the development of novel therapeutic products to treat and manage pain. The company is dedicated towards using its proprietary site-specific nano drug delivery technology to establish a product development pipeline. It adopted a new business plan which seeks to enhance the company's performance. The company's pipeline consists of two candidates, namely, Indaflex and ARX-8203 for the pain market. AlphaRX's online video business, UMeLook focuses on providing unique foreign video content to Chinese viewers.

AlphaRx, Inc.Key Recent Developments

Feb 07, 2012: AlphaRx Reports Q1 Fiscal 2012 Resultsn

This comprehensive SWOT profile of AlphaRx, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
AlphaRx, Inc. - Key Facts
AlphaRx, Inc. - Key Employees
AlphaRx, Inc. - Key Employee Biographies
AlphaRx, Inc. - Major Products and Services
AlphaRx, Inc. - Pharmaceutical Pipeline Products Data
AlphaRx, Inc., Pipeline Products by Therapy Area
AlphaRx, Inc., Pipeline Products by Development Phase
AlphaRx, Inc. - History
AlphaRx, Inc. - Company Statement
AlphaRx, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
AlphaRx, Inc. - Business Description
AlphaRx, Inc. - SWOT Analysis
SWOT Analysis - Overview
AlphaRx, Inc. - Strengths
Strength - Proprietary High Value Platform Technology
Strength - Focused Research and Development Activities
Strength - Strong Patent Portfolio
AlphaRx, Inc. - Weaknesses
Weakness - History of Operating Losses
AlphaRx, Inc. - Opportunities
Opportunity - Strategic Acqusition - UMeLook
Opportunity - Pain Management: Market Potential
AlphaRx, Inc. - Threats
Threat - Intense Competition
Threat - Stringent Government Regulations
Threat - Product Liability Claims
AlphaRx, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AlphaRx, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
AlphaRx, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
AlphaRx, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
AlphaRx, Inc., Recent Developments
Feb 07, 2012: AlphaRx Reports Q1 Fiscal 2012 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
AlphaRx, Inc., Key Facts
AlphaRx, Inc., Key Employees
AlphaRx, Inc., Key Employee Biographies
AlphaRx, Inc., Major Products and Services
AlphaRx, Inc., Number of Pipeline Products by Therapy Area
AlphaRx, Inc., Number of Pipeline Products by Development Stage
AlphaRx, Inc., Pipeline Products By Therapy Area and Development Phase
AlphaRx, Inc., History
AlphaRx, Inc., Subsidiaries
AlphaRx, Inc., Key Competitors
AlphaRx, Inc., Ratios based on current share price
AlphaRx, Inc., Annual Ratios
AlphaRx, Inc., Interim Ratios
AlphaRx, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
AlphaRx, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
AlphaRx, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
AlphaRx, Inc., Pipeline Products by Therapy Area
AlphaRx, Inc., Pipeline Products by Development Phase
AlphaRx, Inc., Performance Chart (2008 - 2012)
AlphaRx, Inc., Ratio Charts
AlphaRx, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
AlphaRx, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

IBEX Technologies Inc.
IntelGenx Corp.
Covalon Technologies Ltd.
Isotechnika Pharma Inc.
Afexa Life Sciences Inc.
Paladin Labs Inc.
Aptalis
AEterna Zentaris Inc.

Customers who bought this item also bought

• Private Tutoring - Global Strategic Business Report
• Charter Schools - Global Outlook
• eLEARNING - Global Strategic Business Report
• Generic Defense Strategies: Lifecycle Management Strategies to Maximize Revenue in the Face of Growing Generic Competition
• Education Services - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• International Military and Civilian Unmanned Aerial Vehicle Survey
• Commercial And Military Flight Simulation - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020